PTPRC and neoplasm: In contrast to regressing tumors, the TME was largely dominated by TAM-2, which represented over 45% of the total CD45+ infiltrates, followed by TAM-1 and mMDSC (Figure 6C), and resembled very closely to mock treated tumor (Figure 3C).